AU1865297A - Methods and nucleic immunogenic compositions encoding antigens and co-stimulatory molecules for immunization - Google Patents
Methods and nucleic immunogenic compositions encoding antigens and co-stimulatory molecules for immunizationInfo
- Publication number
- AU1865297A AU1865297A AU18652/97A AU1865297A AU1865297A AU 1865297 A AU1865297 A AU 1865297A AU 18652/97 A AU18652/97 A AU 18652/97A AU 1865297 A AU1865297 A AU 1865297A AU 1865297 A AU1865297 A AU 1865297A
- Authority
- AU
- Australia
- Prior art keywords
- immunization
- nucleic
- methods
- immunogenic compositions
- stimulatory molecules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000003053 immunization Effects 0.000 title 1
- 238000002649 immunization Methods 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70532—B7 molecules, e.g. CD80, CD86
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61255396A | 1996-03-08 | 1996-03-08 | |
US08612553 | 1996-03-08 | ||
PCT/CA1997/000162 WO1997032987A1 (en) | 1996-03-08 | 1997-03-07 | Methods and nucleic immunogenic compositions encoding antigens and co-stimulatory molecules for immunization |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1865297A true AU1865297A (en) | 1997-09-22 |
Family
ID=24453660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU18652/97A Abandoned AU1865297A (en) | 1996-03-08 | 1997-03-07 | Methods and nucleic immunogenic compositions encoding antigens and co-stimulatory molecules for immunization |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1865297A (en) |
WO (1) | WO1997032987A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7223739B1 (en) | 1995-06-07 | 2007-05-29 | Powderject Vaccines, Inc. | Adjuvanted genetic vaccines |
JP4312265B2 (en) * | 1997-04-09 | 2009-08-12 | ラング−ジ チャン | Animal model for vaccine evaluation |
US6730512B2 (en) | 1997-04-09 | 2004-05-04 | Amdl, Inc. | Combination immunogene therapy |
NZ505876A (en) * | 1998-01-16 | 2002-12-20 | Univ Johns Hopkins | Solid nanosphere composition and delivery of a coacervate polymeric cation (gelatine or chitosan) and a polyanion (nucleic acids) |
EP1518927A3 (en) * | 1998-02-11 | 2005-06-22 | Maxygen, Inc. | Optimization of immunomodulatory properties of genetic vaccines |
AU2674299A (en) * | 1998-02-11 | 1999-08-30 | Maxygen, Inc. | Targeting of genetic vaccine vectors |
US6881723B1 (en) | 1998-11-05 | 2005-04-19 | Powderject Vaccines, Inc. | Nucleic acid constructs |
US6734172B2 (en) * | 1998-11-18 | 2004-05-11 | Pacific Northwest Research Institute | Surface receptor antigen vaccines |
US7022320B1 (en) | 1999-02-09 | 2006-04-04 | Powderject Vaccines, Inc. | Mycobacterium tuberculosis immunization |
US20030236389A1 (en) * | 2000-12-15 | 2003-12-25 | Shimkets Richard A. | Proteins, polynucleotides encoding them and methods of using the same |
US7196066B1 (en) | 1999-11-03 | 2007-03-27 | Powderject Vaccines, Inc. | DNA-vaccines based on constructs derived from the genomes of human and animal pathogens |
AU1358501A (en) * | 1999-11-03 | 2001-05-14 | Powderject Vaccines, Inc. | Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression |
GB0719509D0 (en) * | 2007-10-05 | 2007-11-14 | Isis Innovation | Molecular adjuvant |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0714308A4 (en) * | 1993-08-26 | 1998-07-29 | Univ California | METHOD, COMPOSITIONS AND DEVICES FOR THE DELIVERY OF NAKED POLYNUCLEOTIDES THAT ENCODE BIOLOGICALLY ACTIVE PEPTIDES |
-
1997
- 1997-03-07 WO PCT/CA1997/000162 patent/WO1997032987A1/en active Application Filing
- 1997-03-07 AU AU18652/97A patent/AU1865297A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1997032987A1 (en) | 1997-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2903999A (en) | Methods and compositions of chemokine-tumor antigen fusion proteins as cancer vaccines | |
WO1997009428A3 (en) | Compounds and methods for immunotherapy and diagnosis of tuberculosis | |
WO1998016646A3 (en) | Compounds and methods for immunotherapy and diagnosis of tuberculosis | |
AU6304996A (en) | Vaccines against hepatitis c | |
IL137442A0 (en) | Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination | |
WO1998053075A3 (en) | Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use | |
EP0882134B8 (en) | Methods and compositions for protective and therapeutic genetic immunization | |
WO1999042076A3 (en) | Compounds and methods for immunotherapy and diagnosis of tuberculosis | |
AU2421397A (en) | Improving binding affinity of antigenic peptides for mhc molecules | |
AU1865297A (en) | Methods and nucleic immunogenic compositions encoding antigens and co-stimulatory molecules for immunization | |
AU7694796A (en) | Tumour vaccine and processes for preparing it | |
AU8068694A (en) | Dendritic cell-specific antibodies and methods for their preparation | |
AU7237391A (en) | Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine | |
AU2981395A (en) | Method of identifying and producing antigen peptides and use thereof as vaccines | |
AU3709495A (en) | Nucleic acid preparation for immunization and method for immunization using the same | |
AU3670697A (en) | Recombinant pox virus for immunization against tumor-associated antigens | |
AU3552797A (en) | Vaccine preparations | |
AU2540897A (en) | Methods and compositions of chimeric polypeptides for tumor antigen vaccines | |
AU1829097A (en) | Methods for regenerating scarless skin and compositions used therein | |
AU6969798A (en) | (pasteurella haemolytica) vaccine | |
IL118538A0 (en) | Oral immunization of pneumococcal antigens | |
AU8392898A (en) | Method of dna vaccination using dna encoding antigen and encoding il6 | |
AU7442296A (en) | Generating d-peptides: methods and compositions | |
AU6559996A (en) | Process for the recovery of methyl polysiloxanes in the form of methyl cyclosiloxanes | |
AU5873094A (en) | Multivalent ab1 antibodies as vaccines |